Date
Category
Learning how to spot a fake COA is one of the few quality controls a buyer of research-use-only materials actually holds. No regulator reviews a research peptide before it ships, and no agency confirms that the purity figure printed on the document matches what is inside the vial.
That gap is structural rather than accidental. It is also the reason supplier evaluation carries more weight in this category than in almost any other laboratory purchase.
This content is provided for informational and educational purposes only and does not constitute medical, pharmaceutical, or legal advice. The products discussed are intended for laboratory research purposes only and are not for human or animal consumption. They are not intended to diagnose, treat, cure, or prevent any disease.
This guide covers what separates an authentic certificate of analysis from a fabricated one, how to confirm that the testing laboratory named on a report actually exists and holds current accreditation, and what to ask a supplier before an order is placed.
A note on scope. This article is about evaluating the document and the supplier behind it. For a section-by-section walkthrough of what each field on a report means, the COA reading guide covers the mechanics in detail.
Why Verification Sits With the Buyer for Research Use Only Materials
Research Use Only (RUO) is a designation, not a certification. It describes the stage a material sits at, and it carries labelling obligations for the supplier. It does not involve any agency reviewing purity, identity, or documentation before a sale.
The distinction matters. In the United States, an RUO product is one in the laboratory research phase of development, and the U.S. Food and Drug Administration has stated that simply placing an RUO label on a product does not exempt it from otherwise applicable requirements (FDA, 2013).
What that means in practice: the label constrains how a supplier may represent and distribute a material. It does not certify anything about what is in the container. The broader regulatory context is covered in the research use only explainer.
No pre-market review means no external quality check
Approved pharmaceutical products pass through a review process before reaching the market. Identity, purity limits, manufacturing controls, and impurity profiles are all examined by an agency before a product is cleared.
Research materials do not travel that path. Every layer of verification that a regulator would otherwise perform falls to the person placing the order.
The regulated world does not accept a COA at face value either
This is the part most buyers miss. Even inside pharmaceutical manufacturing, where suppliers operate under current good manufacturing practice requirements, a supplier report of analysis is treated as a starting point rather than a conclusion.
Under United States regulation, a manufacturer may accept a report of analysis from a component supplier only if it conducts at least one specific identity test itself, and only if it establishes the reliability of that supplier's analyses through validation at appropriate intervals (eCFR, 2026).
Firms have been cited for skipping exactly that step. In one enforcement action, a company was found to have relied on supplier certificates of analysis without conducting identity testing or validating supplier results (FDA, 2019).
The takeaway is simple. A certificate of analysis is evidence, not proof. Independent verification is the expected standard even in the most tightly controlled corner of the industry, which is a reasonable benchmark for a research purchase where no oversight exists at all.
Third-Party Testing Versus In-House Testing
The phrase "lab tested" appears on nearly every research supply site. It is close to meaningless on its own, because it does not say who performed the test or whether that party had any independence from the seller.
There are three arrangements a buyer will encounter, and they are not equivalent.
Arrangement | Who runs the analysis | Independence | What a report proves |
|---|---|---|---|
Accredited third-party lab | An external laboratory holding ISO/IEC 17025 accreditation | High. The laboratory has no commercial stake in the result | Identity and purity assessed by a party audited against an international competence standard |
Unaccredited third-party lab | An external laboratory with no accreditation | Moderate. Independent, but competence is unverified | Results were produced outside the supplier, though method validity is unconfirmed |
In-house or supplier testing | The supplier or its manufacturer | Low. The party reporting the result also sells the material | Internal process control only |
What accreditation actually means
ISO/IEC 17025 is the international standard that specifies general requirements for the competence, impartiality, and consistent operation of testing and calibration laboratories (ISO, 2017). Accreditation bodies use it as the criteria against which laboratories are assessed (ANAB, 2026).
Accreditation is not a one-time certificate. Laboratories are reassessed on a recurring schedule, must participate in proficiency testing, and can be suspended or withdrawn.
In the United States, the primary accreditation bodies for testing laboratories are A2LA, ANAB, and IAS, each of which is recognized by federal agencies for laboratory accreditation purposes (U.S. EPA, 2020).
Why the scope of accreditation matters
This is the detail that catches out even careful buyers. Accreditation is granted for a defined scope, not for a laboratory as a whole.
A laboratory accredited for microbiological food testing is not thereby accredited for peptide purity analysis by high performance liquid chromatography. A certificate number that checks out in a directory can still be attached to a scope that has nothing to do with the analysis on the report in front of you.
In-house testing is not automatically a red flag
Internal quality control has a legitimate place. Manufacturers test their own material as a matter of routine process control, and that testing is often competent.
The problem is not the existence of in-house data. The problem is in-house data presented as independent verification, or a supplier that offers nothing else.
The Red Flag Checklist: How to Spot a Fake COA
Fabricated and recycled test reports are a documented problem, not a hypothetical one. In a 2024 communication, the FDA reported an increasing number of third-party test laboratories generating data that was fabricated, duplicated from other submissions, or otherwise unreliable (FDA, 2024).
That advisory concerned medical device submissions, where a regulator was reviewing the paperwork. In a research supply transaction, nobody is reviewing it except the buyer.
Here is what to look for.
Red flag | What it usually indicates |
|---|---|
No batch or lot number | The report cannot be tied to the material being sold |
No date of analysis or date of receipt | The report may predate the batch entirely |
No testing laboratory named | There may be no external laboratory involved |
No analytical method or instrument listed | Results cannot be evaluated or reproduced |
No chromatogram or spectrum, only a summary table | The underlying data has not been shown |
Identical document across multiple products | A single report is being reused as a template |
Purity stated as a round figure on every product | Numbers were selected rather than measured |
Low-resolution image rather than a document | Common in altered or cropped reports |
Accreditation claimed but no certificate number | The claim cannot be checked |
Report only available after payment | Verification has been placed after the point of no return |
Missing batch and date information
A certificate of analysis that cannot be tied to a specific lot is not a certificate of analysis. It is a marketing document with test-shaped content.
ISO/IEC 17025 sets out minimum content for test reports, including unambiguous identification of the item tested, the date of receipt, and a unique report identifier (ISO, 2017). A document missing these fields would not satisfy the standard it is implicitly invoking.
The same document reused across products or lots
Open two reports from the same supplier for two different compounds. Compare the report numbers, the dates, the retention times, and the shape of the traces.
If the chromatograms are visually identical for two different molecules, the document has been reused. Different sequences do not produce the same trace, a point that follows directly from how these materials are made and separated, as covered in the peptide synthesis overview.
No named laboratory, method, or instrument
A real report states what was run and on what. Expect to see the analytical technique, the column or instrument configuration, and the method reference.
Purity by HPLC and identity by mass spectrometry are the two standard layers for this material class, and they answer different questions. The purity testing explainer covers what each technique measures and why one without the other is incomplete.
Purity figures that do not behave like real measurements
Real analytical data is untidy. Purity values land at 98.4 percent or 99.2 percent, they vary between lots, and they are accompanied by a chromatogram showing where the remaining percentage went.
For context on what serious characterization looks like when a regulator is doing the reviewing: in the drug approval context, impurities present above 0.10 percent of the drug substance are expected to be individually identified and characterized (FDA, 2021). That threshold does not apply to research materials, but it illustrates the gap between a stated purity percentage and an actual impurity profile.
A supplier that reports 99.9 percent purity across an entire catalogue is reporting a decision, not a measurement.
How to Verify That a Certificate of Analysis Is Authentic
Reading a report critically is the first half. Confirming it independently is the second, and it takes about ten minutes.
Step 1. Identify the testing laboratory by name and location. If the report does not name one, verification stops here and the answer is no.
Step 2. Search the accreditation body's public directory. A2LA, ANAB, and IAS each publish searchable directories of accredited organizations. Search by laboratory name or certificate number in the A2LA directory or the equivalent register for the body named.
Step 3. Confirm the scope covers the analysis. Open the scope document attached to the certificate. Look for chemical testing by chromatography or mass spectrometry, not simply the laboratory's name on a list.
Step 4. Check the suspended, withdrawn, and false-claims listings. Accreditation bodies publish these. A2LA maintains a public register of organizations claiming accreditation they do not hold, including cases where a quoted certificate number belonged to a different laboratory entirely (A2LA, 2026).
The same pattern appears elsewhere. IAS has documented organizations whose accreditation was cancelled while their websites continued to display the certificate (IAS, 2026).
Step 5. Contact the laboratory with the report number. Accredited laboratories will confirm whether a report identifier corresponds to work they performed. This single step defeats most fabricated documents.
Step 6. Match the lot number on the report to the vial. A verified report for a different batch tells you nothing about the material in front of you.
What to Ask a Supplier Before You Order
The questions below are not adversarial. A supplier operating properly answers all of them quickly, and the speed of the answer is itself informative.
Is the COA for this specific lot available before purchase? Documentation held back until after payment removes the only leverage a buyer has.
Which laboratory performed the analysis, and what is its accreditation number? A name without a number cannot be checked.
What methods were used for identity and for purity? Two separate answers are expected. One answer covering both suggests only one test was run.
Can the chromatogram and mass spectrum be provided, not only the summary? Summary tables are assertions. Traces are data.
What is the retest or re-analysis interval for stored inventory? Material tested two years ago and stored since then has a documentation gap, a point connected to the chemistry of peptide lyophilization.
Is the CAS number listed and does it match the compound named? Identifier mismatches are a common and easily checked inconsistency, as explained in the CAS number guide.
At Janera Science, current batch documentation is published on the lab results page rather than supplied on request after an order. Further questions about documentation are answered through the contact page.
Frequently Asked Questions
What is a fake COA?
A fake COA is a certificate of analysis that misrepresents the testing behind it. This includes documents fabricated without any analysis performed, reports copied from one product or lot to another, altered documents where figures have been edited, and reports attributed to a laboratory that did not conduct the work or does not exist.
Can a certificate of analysis be verified without contacting the supplier?
Partly. The accreditation status and scope of the named testing laboratory can be checked independently through public accreditation directories, and the laboratory itself can usually confirm whether a report number corresponds to work it performed. The lot number on the document, however, can only be matched against the material once it is received.
Does ISO/IEC 17025 accreditation guarantee a result is accurate?
No. ISO/IEC 17025 addresses the competence, impartiality, and consistent operation of a laboratory (ISO, 2017). It establishes that a laboratory has been assessed as technically competent within a defined scope. It does not certify any individual result, and accreditation for one field of testing does not extend to others.
Why do research suppliers publish COAs at all if they are not required to?
Publication is a commercial and reputational decision rather than a regulatory obligation for research materials. Suppliers that publish current batch documentation openly are accepting a standard of scrutiny that a regulator does not impose on them, which is itself a signal.
Is in-house testing acceptable for research peptides?
In-house analysis is a normal part of manufacturing process control and is not inherently a problem. The concern arises when internal data is presented as independent third-party verification, or when a supplier can produce nothing beyond its own results.
What does a purity percentage on a COA actually describe?
A purity percentage from HPLC describes the proportion of material detected in the chromatogram attributable to the target compound. It does not describe net peptide content, counter-ion content, or water content, which are reported separately. The COA reading guide covers how those figures relate to one another.
How recent should a certificate of analysis be?
The relevant question is not calendar age but whether the report corresponds to the lot being supplied. A report from eighteen months ago for the exact lot in inventory is more useful than a recent report for a different batch.
Key Takeaways
Research Use Only is a designation, not a certification. No agency reviews identity or purity before a research material is sold, which places the entire verification burden on the buyer (FDA, 2013).
Even regulated manufacturers do not accept a supplier COA at face value. United States regulation requires an independent identity test plus periodic validation of supplier results before a report of analysis may be relied upon (eCFR, 2026).
Fabricated and duplicated laboratory data is a documented problem. The FDA has reported rising numbers of third-party laboratories producing data that was fabricated or copied from other submissions (FDA, 2024).
Accreditation claims are checkable in about ten minutes. Accreditation bodies publish searchable directories alongside public registers of suspended certificates and false accreditation claims (A2LA, 2026).
Accreditation scope matters as much as accreditation status. A laboratory accredited for an unrelated field of testing does not provide valid documentation for peptide purity analysis (ISO, 2017).
Every batch verified
Janera Science publishes third-party Certificates of Analysis for its research peptides. To review identity, purity, and analytical verification for current material, visit our lab results page. For the regulatory context behind how these materials are supplied, see our overview of what Research Use Only means.
